Analysis/NN
of/IN
the/DT
ligand-binding/JJ
domain/NN
of/IN
human/JJ
retinoic/JJ
acid/NN
receptor/NN
alpha/NN
by/IN
site-directed/JJ
mutagenesis/NN
./.

Three/CD
subtypes/NNS
of/IN
retinoic/JJ
acid/NN
receptors/NNS
(/(
RAR/NN
)/)
,/,
termed/VBN
RAR/NN
alpha/NN
,/,
RAR/NN
beta/NN
,/,
and/CC
RAR/NN
gamma/NN
,/,
have/VBP
been/VBN
described/VBN
./.
=====
They/PRP
are/VBP
composed/VBN
of/IN
different/JJ
structural/JJ
domains/NNS
,/,
including/VBG
distinct/JJ
domains/NNS
for/IN
DNA/NN
and/CC
ligand/NN
binding/NN
./.
=====
RARs/NNS
specifically/RB
bind/VBP
all-trans-retinoic/JJ
acid/NN
(/(
RA/NN
)/)
,/,
9-cis-RA/NN
,/,
and/CC
retinoid/JJ
analogs/NNS
./.
=====
In/IN
this/DT
study/NN
,/,
we/PRP
examined/VBD
the/DT
functional/JJ
role/NN
of/IN
cysteine/NN
and/CC
arginine/NN
residues/NNS
in/IN
the/DT
ligand-binding/JJ
domain/NN
of/IN
hRAR/NN
alpha/NN
(/(
hRAR/NN
alpha-LBD/NN
,/,
amino/NN
acids/NNS
154/CD
to/TO
462/CD
)/)
./.
=====
All/DT
conserved/VBN
cysteine/NN
and/CC
arginine/NN
residues/NNS
in/IN
this/DT
domain/NN
were/VBD
mutated/VBN
by/IN
site-directed/JJ
mutagenesis/NN
,/,
and/CC
the/DT
mutant/JJ
proteins/NNS
were/VBD
characterized/VBN
by/IN
blocking/VBG
reactions/NNS
,/,
ligand-binding/JJ
experiments/NNS
,/,
transactivation/NN
assays/NNS
,/,
and/CC
protease/NN
mapping/NN
./.
=====
Changes/NNS
of/IN
any/DT
cysteine/JJ
residue/NN
of/IN
the/DT
hRAR/NN
alpha-LBD/NN
had/VBD
no/DT
significant/JJ
influence/NN
on/IN
the/DT
binding/NN
of/IN
all-trans/JJ
RA/NN
or/CC
9-cis/JJ
RA/NN
./.
=====
Interestingly/RB
,/,
residue/JJ
C-235/NN
is/VBZ
specifically/RB
important/JJ
in/IN
antagonist/NN
binding/NN
./.
=====
With/IN
respect/NN
to/TO
arginine/NN
residues/NNS
,/,
only/RB
the/DT
two/CD
single/JJ
mutations/NNS
of/IN
R-276/NN
and/CC
R-394/NN
to/TO
alanine/NN
showed/VBD
a/DT
dramatic/JJ
decrease/NN
of/IN
agonist/NN
and/CC
antagonist/NN
binding/NN
whereas/IN
the/DT
R272A/NN
mutation/NN
showed/VBD
only/RB
a/DT
slight/JJ
effect/NN
./.
=====
For/IN
all/DT
other/JJ
arginine/NN
mutations/NNS
,/,
no/DT
differences/NNS
in/IN
affinity/NN
were/VBD
detectable/JJ
./.
=====
The/DT
two/CD
mutations/NNS
R217A/NN
and/CC
R294A/NN
caused/VBD
an/DT
increased/VBN
binding/NN
efficiency/NN
for/IN
antagonists/NNS
but/CC
no/DT
change/NN
in/IN
agonist/NN
binding/NN
./.
=====
From/IN
these/DT
results/NNS
,/,
we/PRP
can/MD
conclude/VB
that/IN
electrostatic/JJ
interactions/NNS
of/IN
retinoids/NNS
with/IN
the/DT
RAR/NN
alpha-LBD/NN
play/VBP
a/DT
significant/JJ
role/NN
in/IN
ligand/NN
binding/NN
./.
=====
In/IN
addition/NN
,/,
antagonists/NNS
show/VBP
distinctly/RB
different/JJ
requirements/NNS
for/IN
efficient/JJ
binding/NN
,/,
which/WDT
may/MD
contribute/VB
to/TO
their/PRP$
interference/NN
in/IN
the/DT
ligand-inducible/JJ
transactivation/NN
function/NN
of/IN
RAR/NN
alpha/NN
./.